Further studies of the role of transforming growth factor-beta in human B cell function - PubMed (original) (raw)

. 1989 Sep 15;143(6):1868-74.

Affiliations

• PMID: 2550546

Further studies of the role of transforming growth factor-beta in human B cell function

J H Kehrl et al. J Immunol. 1989.

Abstract

This study was designed to address three specific questions in human B cells. First, to determine whether transforming growth factor-beta (TGF-beta)2 has similar biologic effects on B cell function as does TGF-beta 1. Second, to test the hypothesis that TGF-beta 1 is an autocrine growth and differentiation inhibitor. Finally, because multiple receptor species for TGF-beta have been identified on other cell types, to determine by chemical cross-linking and competitive binding studies the nature of the TGF-beta 1 R present on normal and transformed B cells. Exogenous TGF-beta 2 was found to be functionally similar to TGF-beta 1 in its inhibition of factor dependent normal B cell proliferation and Ig secretion. When an antibody, specific for the active form of TGF-beta 1, was added in conjunction with IL-2 to previously stimulated B cell cultures, there was a 14.4 +/- 4.2% increase in B cell proliferation, a 22 +/- 6% increase in IgG production, and a 33 +/- 8.6% increase in IgM production when compared to control cultures. Chemical cross-linking of 125I-TGF-beta 1 to normal B cell membranes identified two major cross-linked species of 65 and 90 kDa. A fivefold excess of unlabeled TGF-beta 1 competitively inhibited the detection of both of these bands while a 50-fold excess of unlabeled TGF-beta 2 did not inhibit the 90-kDa band and only partially inhibited (60%) of the 65-kDa band. Chemical cross-linking of 125I-TGF-beta 1 to transformed B cell membranes identified only a single band of 60 kDa. Scatchard plot analysis of 125I-TGF-beta 1 binding to normal B cells that was competitively inhibited with increasing concentrations of unlabeled TGF-beta 1 revealed both high and low affinity binding sites whereas analysis of 125I-TGF-beta 1 binding in the presence of increasing concentrations of unlabeled TGF-beta 2 revealed only low affinity sites. These findings demonstrate that TGF-beta 2 is as effective as TGF-beta 1 in inhibiting human B cell function, that small amounts of active TGF-beta 1 are present endogenously in in vitro cultures which partially inhibit B cell function, that two major TGF-beta 1 R cross-linked complexes of 65 and 90 kDa are present on normal B cells, and that transformation of B cells may be accompanied by changes in the TGF-beta 1 R.

PubMed Disclaimer

Similar articles

• Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
  Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. Kehrl JH, et al. J Immunol. 1986 Dec 15;137(12):3855-60. J Immunol. 1986. PMID: 2878044
• Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
  Kumar A, Rogers T, Maizel A, Sharma S. Kumar A, et al. J Immunol. 1991 Aug 1;147(3):998-1006. J Immunol. 1991. PMID: 1713611
• Role of transforming growth factor-beta in bone remodeling.
  Bonewald LF, Mundy GR. Bonewald LF, et al. Clin Orthop Relat Res. 1990 Jan;(250):261-76. Clin Orthop Relat Res. 1990. PMID: 2403492 Review.
• Transforming growth factors beta.
  Hsuan JJ. Hsuan JJ. Br Med Bull. 1989 Apr;45(2):425-37. doi: 10.1093/oxfordjournals.bmb.a072332. Br Med Bull. 1989. PMID: 2557115 Review.

Cited by

• TGFβ Superfamily Members as Regulators of B Cell Development and Function-Implications for Autoimmunity.
  Tamayo E, Alvarez P, Merino R. Tamayo E, et al. Int J Mol Sci. 2018 Dec 7;19(12):3928. doi: 10.3390/ijms19123928. Int J Mol Sci. 2018. PMID: 30544541 Free PMC article. Review.
• TGF-β3 Inhibits Antibody Production by Human B Cells.
  Tsuchida Y, Sumitomo S, Ishigaki K, Suzuki A, Kochi Y, Tsuchiya H, Ota M, Komai T, Inoue M, Morita K, Okamura T, Yamamoto K, Fujio K. Tsuchida Y, et al. PLoS One. 2017 Jan 4;12(1):e0169646. doi: 10.1371/journal.pone.0169646. eCollection 2017. PLoS One. 2017. PMID: 28052118 Free PMC article.
• Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.
  Campion EM, Hakimjavadi R, Loughran ST, Phelan S, Smith SM, D'Souza BN, Tierney RJ, Bell AI, Cahill PA, Walls D. Campion EM, et al. J Virol. 2014 May;88(9):5001-13. doi: 10.1128/JVI.03642-13. Epub 2014 Feb 19. J Virol. 2014. PMID: 24554662 Free PMC article.
• The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression.
  Jelicic K, Cimbro R, Nawaz F, Huang da W, Zheng X, Yang J, Lempicki RA, Pascuccio M, Van Ryk D, Schwing C, Hiatt J, Okwara N, Wei D, Roby G, David A, Hwang IY, Kehrl JH, Arthos J, Cicala C, Fauci AS. Jelicic K, et al. Nat Immunol. 2013 Dec;14(12):1256-65. doi: 10.1038/ni.2746. Epub 2013 Oct 27. Nat Immunol. 2013. PMID: 24162774 Free PMC article.
• Transforming growth factor-beta and multidrug resistance in chronic lymphocytic leukemia.
  Friedenberg WR, Salzman SA, Phan SM, Burmester JK. Friedenberg WR, et al. Med Oncol. 1999 Jul;16(2):110-8. doi: 10.1007/BF02785844. Med Oncol. 1999. PMID: 10456659

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database